Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Addressing the “risk off” investment challenge
5th Jun 2025
Pharma thoughts | Good move by GSK?
30th May 2025
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
Update on The EIS Navigator podcast
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Update
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Surface Transforms
Industrial
Open Offer
By
Mike Foster
09 May 2024
City of London Investment Group
Investment Companies
Positive inflows boost FUM
By
Dr Brian Moretta
01 May 2024
Stay up-to-date with the latest research
Sign up to our newsletter
Chesnara Plc
Financials
Good 2023 results set platform for future progress
By
Dr Brian Moretta
11 Apr 2024
Tissue Regenix
Life Sciences
Six consecutive periods of >20% growth
By
Dr Martin Hall
10 Apr 2024
Arbuthnot Banking Group Plc
Financials
2023: delivering strategy with strong profit growth
By
Mark Thomas
08 Apr 2024
H&T Group
Financials
Core franchise build, short-term retail noise
By
Mark Thomas
04 Apr 2024
The International Stock Exchange
Financials
Very strong full-year performance
By
Jason Streets
04 Apr 2024
NB Private Equity Partners
Investment Companies
Value creation in a higher-rate environment
By
Mark Thomas
07 Mar 2024
City of London Investment Group
Investment Companies
First-half results going in the right direction
By
Dr Brian Moretta
06 Mar 2024
Real Estate Credit Investments (RECI)
Investment Companies
French and German exposures in perspective
By
Mark Thomas
27 Feb 2024
City of London Investment Group
Investment Companies
Bounce back in FUM after strong quarter
By
Dr Brian Moretta
31 Jan 2024
Prev
1
...
3
4
5
6
7
...
32
Next
